Published in Kidney Int on February 01, 2003
Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med (2014) 5.01
Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med (2013) 3.83
Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol (2009) 1.36
Access to care and the incidence of end-stage renal disease due to diabetes. Diabetes Care (2009) 1.26
Predictors of autosomal dominant polycystic kidney disease progression. J Am Soc Nephrol (2014) 1.24
Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark. Clin J Am Soc Nephrol (2010) 1.19
Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol (2009) 1.14
Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease. Am J Nephrol (2012) 1.06
Developments in the management of autosomal dominant polycystic kidney disease. Ther Clin Risk Manag (2008) 1.06
Aquaporin-1 and -9 are differentially regulated by oestrogen in the efferent ductule epithelium and initial segment of the epididymis. Biol Cell (2005) 1.02
Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD). Biochim Biophys Acta (2011) 1.01
Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries. Clin J Am Soc Nephrol (2008) 0.94
Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2011) 0.87
Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience. Clin Exp Nephrol (2012) 0.85
Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage. Am J Physiol Renal Physiol (2015) 0.85
Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease. Am J Kidney Dis (2013) 0.84
The impact of type II diabetes mellitus in patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2011) 0.84
A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease. BMC Nephrol (2015) 0.84
Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants. Contemp Clin Trials (2011) 0.83
ADPKD: Prototype of Cardiorenal Syndrome Type 4. Int J Nephrol (2010) 0.81
Identification of people with autosomal dominant polycystic kidney disease using routine data: a cross sectional study. BMC Nephrol (2014) 0.80
Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry. BMC Nephrol (2013) 0.80
A comparison of the effects of losartan and ramipril on blood pressure, renal volume and progression in polycystic kidney disease: A 5-Year follow-up. Hippokratia (2012) 0.79
Effect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK Rats. PLoS One (2015) 0.78
Autosomal dominant polycystic kidney disease and transplantation. Ann Transplant (2009) 0.78
Congenital/inherited kidney diseases: how to identify them early and how to manage them. Clin Exp Nephrol (2005) 0.77
Caffeine intake by patients with autosomal dominant polycystic kidney disease. Braz J Med Biol Res (2012) 0.76
Single-nucleotide polymorphism of the UMOD promoter is associated with the outcome of chronic kidney disease patients. Biomed Rep (2015) 0.75
Renin gene rs1464816 polymorphism contributes to chronic kidney disease progression in ADPKD. J Biomed Sci (2016) 0.75
Quantification of angiotensin II-regulated proteins in urine of patients with polycystic and other chronic kidney diseases by selected reaction monitoring. Clin Proteomics (2016) 0.75
Detection of blast-related traumatic brain injury in U.S. military personnel. N Engl J Med (2011) 5.34
Modifier genes play a significant role in the phenotypic expression of PKD1. Kidney Int (2005) 2.03
Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study. Am J Kidney Dis (2002) 1.92
Autosomal-dominant polycystic kidney disease in infancy and childhood: progression and outcome. Kidney Int (2005) 1.72
Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications. Am J Kidney Dis (2005) 1.55
MR evaluation of fetal demise. Pediatr Radiol (2011) 1.43
Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Am J Physiol Endocrinol Metab (2004) 1.24
Congenital high airway obstruction syndrome: MR/US findings, effect on management, and outcome. Pediatr Radiol (2008) 1.12
NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome. Proc Natl Acad Sci U S A (2013) 1.12
Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population. Am J Hypertens (2004) 1.07
DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells. Am J Physiol Endocrinol Metab (2005) 1.03
Variation in age at ESRD in autosomal dominant polycystic kidney disease. Am J Kidney Dis (2008) 1.02
Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells. Prostate (2007) 1.01
Monoamine oxidase-A is a major target gene for glucocorticoids in human skeletal muscle cells. FASEB J (2005) 1.01
Human prostate stromal cells stimulate increased PSA production in DHEA-treated prostate cancer epithelial cells. J Steroid Biochem Mol Biol (2008) 0.99
Functional status after blast-plus-impact complex concussive traumatic brain injury in evacuated United States military personnel. J Neurotrauma (2014) 0.94
The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomal-dominant polycystic kidney disease. Kidney Int (2003) 0.92
Disrupted modular organization of resting-state cortical functional connectivity in U.S. military personnel following concussive 'mild' blast-related traumatic brain injury. Neuroimage (2013) 0.91
Extrafetal findings at fetal MR: evaluation of the normal placenta and correlation with ultrasound. Clin Imaging (2011) 0.89
Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney Int (2003) 0.89
Design and baseline characteristics of participants in the study of antihypertensive therapy in children and adolescents with autosomal dominant polycystic kidney disease (ADPKD). Contemp Clin Trials (2005) 0.87
Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up. J Am Soc Nephrol (2004) 0.87
Patellar sleeve fractures in children: a case report and review of the literature. Am J Orthop (Belle Mead NJ) (2006) 0.84
No effect of angiotensin-converting enzyme gene polymorphism on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease. Am J Nephrol (2003) 0.80
Prenatal MRI evaluation of limb-body wall complex. Pediatr Radiol (2014) 0.79
Low-dose fetal CT for evaluation of severe congenital skeletal anomalies: preliminary experience. Pediatr Radiol (2012) 0.77
Normal Fetal Long Bone Length from Computed Tomography: Potential Value in the Prenatal Evaluation of Skeletal Dysplasias. Fetal Diagn Ther (2016) 0.77
Complex genitourinary abnormalities on fetal MRI: imaging findings and approach to diagnosis. AJR Am J Roentgenol (2012) 0.76
A 2-year-old boy with emesis and facial edema. MedGenMed (2006) 0.75
Right Congenital Diaphragmatic Hernias: Is There a Correlation between Prenatal Lung Volume and Postnatal Survival, as in Isolated Left Diaphragmatic Hernias? Fetal Diagn Ther (2017) 0.75
Optimizing functional MR urography: prime time for a 30-minutes-or-less fMRU. Pediatr Radiol (2015) 0.75
Evaluation of Magnetic Resonance Imaging Safety and Imaging Issues Associated with the Occlusion Balloon Used during Fetoscopic Endoluminal Tracheal Occlusion. Fetal Diagn Ther (2017) 0.75